Mass Tort Intake Best Practices for Law Firms
Where mass tort intake breaks: speed to lead, screening before signature, documentation, TCPA consent records and post-retainer engagement. What to measure.
Operator-level briefings on the litigations we run campaigns for: where each one stands, what a qualified claimant looks like, where intake breaks, and how screening should work.
Where mass tort intake breaks: speed to lead, screening before signature, documentation, TCPA consent records and post-retainer engagement. What to measure.
Where the AFFF firefighting foam MDL stands in September 2026, what a qualified PFAS injury claimant looks like, and how intake fails on this tort.
Where the Eaton and Palisades fire cases stand in September 2026, what a qualified wildfire claimant looks like, and where intake breaks on disaster torts.
Where Camp Lejeune Justice Act claims stand as of September 2026, what the closed 2024 filing window means for firms, and where intake still has work to do.
Where the Depo-Provera meningioma MDL stands in September 2026, what a qualified claimant looks like, where intake fails, and how acquisition works.
Where hair relaxer MDL 3060 stands as of September 2026, what a qualified uterine or ovarian cancer claimant looks like, and where intake fails on proof of use.
Where asbestos and talc mesothelioma litigation stands in September 2026, what a signable claimant looks like, and how intake teams avoid the costly misses.
Where Uber MDL 3084, the Lyft MDL and the California JCCP stand in September 2026, what a qualified survivor claim looks like, and how intake should run.
The practice area, the jurisdiction, and the volume you want. We come back with a campaign structure and pricing before you commit to anything.